NA-931

· Biomed Industries, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NA-931, covering 2024-09-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese [Phase 2]